Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1979 1
1980 2
1982 3
1984 2
1985 3
1986 2
1987 1
1989 2
1990 2
1993 2
1995 3
1996 1
1997 1
1998 3
1999 6
2000 3
2001 2
2003 7
2004 2
2005 2
2006 4
2007 3
2008 2
2009 2
2010 2
2011 5
2012 2
2013 15
2014 25
2015 30
2016 24
2017 16
2018 15
2019 17
2020 13
2021 11
2022 17
2023 18
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Results by year

Filters applied: . Clear all
Page 1
Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events.
Poto R, Troiani T, Criscuolo G, Marone G, Ciardiello F, Tocchetti CG, Varricchi G. Poto R, et al. Front Immunol. 2022 Mar 30;13:804597. doi: 10.3389/fimmu.2022.804597. eCollection 2022. Front Immunol. 2022. PMID: 35432346 Free PMC article. Review.
ICIs provide clinical benefits in a percentage of patients with advanced cancers, but they are usually associated with a remarkable spectrum of immune-related adverse events (irAEs) (e.g., rash, colitis, hepatitis, pneumonitis, endocrine, cardiac and musculoskeletal dysfun …
ICIs provide clinical benefits in a percentage of patients with advanced cancers, but they are usually associated with a remarkable spectrum …
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.
Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK, Comerota AJ, Gornik HL, Murphy TP, Lewis L, Duncan JR, Nieters P, Derfler MC, Filion M, Gu CS, Kee S, Schneider J, Saad N, Blinder M, Moll S, Sacks D, Lin J, Rundback J, Garcia M, Razdan R, VanderWoude E, Marques V, Kearon C; ATTRACT Trial Investigators. Vedantham S, et al. N Engl J Med. 2017 Dec 7;377(23):2240-2252. doi: 10.1056/NEJMoa1615066. N Engl J Med. 2017. PMID: 29211671 Free PMC article. Clinical Trial.
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy.
Marone R, Landmann E, Devaux A, Lepore R, Seyres D, Zuin J, Burgold T, Engdahl C, Capoferri G, Dell'Aglio A, Larrue C, Simonetta F, Rositzka J, Rhiel M, Andrieux G, Gallagher DN, Schröder MS, Wiederkehr A, Sinopoli A, Do Sacramento V, Haydn A, Garcia-Prat L, Divsalar C, Camus A, Xu L, Bordoli L, Schwede T, Porteus M, Tamburini J, Corn JE, Cathomen T, Cornu TI, Urlinger S, Jeker LT. Marone R, et al. J Exp Med. 2023 Dec 4;220(12):e20231235. doi: 10.1084/jem.20231235. Epub 2023 Sep 29. J Exp Med. 2023. PMID: 37773046 Free PMC article.
Selective haematological cancer eradication with preserved haematopoiesis.
Garaudé S, Marone R, Lepore R, Devaux A, Beerlage A, Seyres D, Dell' Aglio A, Juskevicius D, Zuin J, Burgold T, Wang S, Katta V, Manquen G, Li Y, Larrue C, Camus A, Durzynska I, Wellinger LC, Kirby I, Van Berkel PH, Kunz C, Tamburini J, Bertoni F, Widmer CC, Tsai SQ, Simonetta F, Urlinger S, Jeker LT. Garaudé S, et al. Nature. 2024 Jun;630(8017):728-735. doi: 10.1038/s41586-024-07456-3. Epub 2024 May 22. Nature. 2024. PMID: 38778101 Free PMC article.
Eosinophils: The unsung heroes in cancer?
Varricchi G, Galdiero MR, Loffredo S, Lucarini V, Marone G, Mattei F, Marone G, Schiavoni G. Varricchi G, et al. Oncoimmunology. 2017 Nov 13;7(2):e1393134. doi: 10.1080/2162402X.2017.1393134. eCollection 2018. Oncoimmunology. 2017. PMID: 29308325 Free PMC article. Review.
Eosinophils are a source of anti-tumorigenic (e.g., TNF-alpha, granzyme, cationic proteins, and IL-18) and protumorigenic molecules (e.g., pro-angiogenic factors) depending on the milieu. In several neoplasias (e.g., melanoma, gastric, colorectal, oral and pr …
Eosinophils are a source of anti-tumorigenic (e.g., TNF-alpha, granzyme, cationic proteins, and IL-18) and protumorigenic molecules ( …
Basophils from allergy to cancer.
Poto R, Gambardella AR, Marone G, Schroeder JT, Mattei F, Schiavoni G, Varricchi G. Poto R, et al. Front Immunol. 2022 Dec 12;13:1056838. doi: 10.3389/fimmu.2022.1056838. eCollection 2022. Front Immunol. 2022. PMID: 36578500 Free PMC article. Review.
Basophils beyond allergic and parasitic diseases.
Poto R, Loffredo S, Marone G, Di Salvatore A, de Paulis A, Schroeder JT, Varricchi G. Poto R, et al. Front Immunol. 2023 May 2;14:1190034. doi: 10.3389/fimmu.2023.1190034. eCollection 2023. Front Immunol. 2023. PMID: 37205111 Free PMC article. Review.
Evidence is emerging that basophils mediate non-redundant roles in allergic disease and, unsuspectingly, are implicated in a variety of other pathologies [e.g., myocardial infarction, autoimmunity, chronic obstructive pulmonary disease, fibrosis, cancer, etc.]. ...
Evidence is emerging that basophils mediate non-redundant roles in allergic disease and, unsuspectingly, are implicated in a variety of othe …
Eosinophils in the Tumor Microenvironment.
Mattei F, Andreone S, Marone G, Gambardella AR, Loffredo S, Varricchi G, Schiavoni G. Mattei F, et al. Adv Exp Med Biol. 2020;1273:1-28. doi: 10.1007/978-3-030-49270-0_1. Adv Exp Med Biol. 2020. PMID: 33119873 Review.
Are Mast Cells MASTers in Cancer?
Varricchi G, Galdiero MR, Loffredo S, Marone G, Iannone R, Marone G, Granata F. Varricchi G, et al. Front Immunol. 2017 Apr 12;8:424. doi: 10.3389/fimmu.2017.00424. eCollection 2017. Front Immunol. 2017. PMID: 28446910 Free PMC article. Review.
Although canonically associated with allergic disorders, mast cells are a major source of pro-tumorigenic (e.g., angiogenic and lymphangiogenic factors) and antitumorigenic molecules (e.g., TNF-alpha and IL-9), depending on the milieu. In certain neoplasias (e.g …
Although canonically associated with allergic disorders, mast cells are a major source of pro-tumorigenic (e.g., angiogenic and lymph …
Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer.
Modestino L, Cristinziano L, Poto R, Ventrici A, Trocchia M, Ferrari SM, Fallahi P, Paparo SR, Marone G, Antonelli A, Varricchi G, Galdiero MR. Modestino L, et al. Front Immunol. 2023 Aug 29;14:1167404. doi: 10.3389/fimmu.2023.1167404. eCollection 2023. Front Immunol. 2023. PMID: 37705974 Free PMC article.
PMNs contain and release a plethora of mediators, including granular enzymes [e.g., myeloperoxidase (MPO), pentraxin-3 (PTX3) and matrix metalloproteinase-9 (MMP-9)], and neutrophil extracellular traps (NETs). ...
PMNs contain and release a plethora of mediators, including granular enzymes [e.g., myeloperoxidase (MPO), pentraxin-3 (PTX3) and mat …
262 results